Global CRO footprint MAC Clinical Research operates as a full-service, global CRO with a fully owned network of research sites and capabilities from Early Phase to Phase IV, enabling scalable trial management for multinational studies and complex protocols.

Therapeutic breadth Expertise spans CNS, Men’s and Women’s Health, and Dermatology, suggesting cross-selling opportunities across these high-demand therapeutic areas for existing or prospective sponsors seeking diverse trial portfolios.

Sustainability credential EcoVadis bronze medal with top percentile positioning and above-average scores across Environment, Labor & Human Rights, Ethics, and Sustainable Procurement can be leveraged to win RFPs from sponsors prioritizing ESG compliance and responsible outsourcing.

Recent collaborations Recent partnerships with Initiator Pharma and Kariya Pharmaceuticals indicate openness to single-center and specialized early-phase collaborations, signaling potential for joint studies, site access expansions, and targeted outreach to mid-sized biotech partners.

Innovation & media Launch of the MAC: Behind The Trials podcast and emphasis on state-of-the-art facilities (MHRA-accredited units, sleep laboratory, psychedelic testing suites) present opportunities to position MAC as a thought leader and attract innovative sponsors seeking advanced trial capabilities.